Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

June 22, 2021

Study Completion Date

June 22, 2021

Conditions
Chronic Hepatitis B
Interventions
DRUG

Experimental

Experimental group are treated with TenofoBell®

Trial Locations (1)

Unknown

Daegu Chatholic University Medical center, Daegu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY